- |||||||||| Trial primary completion date: IMI PROTECT(WP2): Antidepressants & Fractures (clinicaltrials.gov) - Jul 8, 2014
P=N/A, N=1, Active, not recruiting, Trial primary completion date: Dec 2015 --> Mar 2017 Trial primary completion date: Feb 2014 --> Aug 2014
- |||||||||| Trial primary completion date: Improving Pain and Function in Hip Fracture (clinicaltrials.gov) - Jun 27, 2014
P3, N=164, Completed, Active, not recruiting --> Completed Trial primary completion date: Dec 2014 --> May 2014
- |||||||||| Trial completion, Trial primary completion date: Improving Pain and Function in Hip Fracture (clinicaltrials.gov) - Jun 27, 2014
P3, N=164, Completed, Trial primary completion date: Dec 2014 --> May 2014 Recruiting --> Completed | Trial primary completion date: Dec 2014 --> May 2014
- |||||||||| Trial primary completion date: Pediatric Femur Research Project (clinicaltrials.gov) - Jun 3, 2014
P=N/A, N=145, Active, not recruiting, Trial primary completion date: Feb 2013 --> Feb 2016 Trial primary completion date: Jun 2013 --> Dec 2014
- |||||||||| Enrollment closed: Pediatric Femur Research Project (clinicaltrials.gov) - Jun 3, 2014
P=N/A, N=145, Active, not recruiting, Trial primary completion date: Jun 2013 --> Dec 2014 Enrolling by invitation --> Active, not recruiting
- |||||||||| ropivacaine / Generic mfg., epinephrine / Generic mfg.
Trial primary completion date: Femoral Nerve Block for Femur Fracture Repair in Pediatrics (clinicaltrials.gov) - May 22, 2014 P2, N=40, Enrolling by invitation, Not yet recruiting --> Recruiting Trial primary completion date: Dec 2014 --> Dec 2015
- |||||||||| ropivacaine / Generic mfg., epinephrine / Generic mfg.
Trial completion date: Femoral Nerve Block for Femur Fracture Repair in Pediatrics (clinicaltrials.gov) - May 22, 2014 P2, N=40, Enrolling by invitation, Trial primary completion date: Dec 2014 --> Dec 2015 Trial completion date: Dec 2014 --> Dec 2015
- |||||||||| Trial primary completion date: MotionLoc Study, Femur Fractures (clinicaltrials.gov) - May 20, 2014
P=N/A, N=2, Completed, Trial completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Mar 2014 --> May 2012
- |||||||||| Trial initiation date: MotionLoc Study, Femur Fractures (clinicaltrials.gov) - May 20, 2014
P=N/A, N=2, Completed, Trial primary completion date: Mar 2014 --> May 2012 Initiation date: Mar 2012 --> Apr 2011
- |||||||||| Trial completion date: MotionLoc Study, Femur Fractures (clinicaltrials.gov) - May 20, 2014
P=N/A, N=2, Completed, Initiation date: Mar 2012 --> Apr 2011 Trial completion date: Mar 2014 --> Jan 2013
- |||||||||| Trial completion: MotionLoc Study, Femur Fractures (clinicaltrials.gov) - May 20, 2014
P=N/A, N=2, Completed, Trial completion date: Mar 2014 --> Jan 2013 Enrolling by invitation --> Completed
- |||||||||| Trial termination: INTUIT Hip Fracture Outcome Study (clinicaltrials.gov) - Mar 30, 2014
P=N/A, N=92, Terminated, Not yet recruiting --> Recruiting Recruiting --> Terminated; Could not power primary endpoint due to lost to follow-up rate
- |||||||||| Enrollment change: INTUIT Hip Fracture Outcome Study (clinicaltrials.gov) - Mar 30, 2014
P=N/A, N=92, Terminated, Recruiting --> Terminated; Could not power primary endpoint due to lost to follow-up rate N=125 --> 92
|